Lv11
20 积分 2025-03-17 加入
Cracking the POD24 code in follicular lymphoma
21小时前
求助中
A low lymphocyte‐to‐monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis
3天前
已完结
Follicular lymphoma
1个月前
已完结
Update on follicular lymphoma
1个月前
已完结
Primary myelofibrosis: 2021 update on diagnosis, risk‐stratification and management
5个月前
已完结
Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy
5个月前
已完结
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph’+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
5个月前
已完结
Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
5个月前
已完结
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
5个月前
已完结
Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium
5个月前
已完结
皖公网安备34019202002308
